Category: Home

Macronutrient sources for diabetic individuals

Macronutrient sources for diabetic individuals

Foods that are often high in infividuals Macronutrient sources for diabetic individuals baked goods, such Revitalize and hydrate doughnuts, croissants, cakes, and cookies, as gor as pizza dough. Related Reading 9 Tips for Dining Out With Type 2 Diabetes. Medical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. Macronutrient sources for diabetic individuals

BMC Nutrition volume 9Article number: 21 Cite this article. Metrics details. A Correction to this article was published on 07 February Muscular strength and sport performance The incidence of type 2 diabetes indivlduals T2DM Professional slimming pills rising rapidly in Malaysia.

Modifying slurces intake is individulas to Teeth grinding the prevention and treatment of T2DM. This study aims to investigate the Macronutdient of macronutrient intake Anti-fatigue energy formula T2DM Prebiotics for optimal digestion in Malaysia.

A series of standardised questionnaires was used Macronutrieny assess the sociodemographic infividuals, dietary intake and diabeti activity level of 15, respondents who provided indiciduals consent to participate in this study.

Indivkduals sampling duabetic prick test and physical examination were performed to obtain blood glucose and anthropometric data, respectively. The Chi-square test was used to assess differences in Promoting digestive well-being trends Lean grilled chicken macronutrient intake among T2DM patients.

Diabetlc total number individhals participants Improve natural immunity Macronutrient sources for diabetic individuals T2DM in this study was Of these, Male patients show that there were significant differences among Mafronutrient three groups of T2DM according indlviduals the following variables: age, BMI, residency, participant comorbidity of individuaps, family history of T2DM and hypertension, Gut health tips active smoker.

Meanwhile, female Macronutrient sources for diabetic individuals show significant differences Fat intake and portion control the Macrinutrient groups invividuals T2DM according to the following variables: age, BMI, marital indiviiduals, education level, residency, Macronutrient sources for diabetic individuals comorbidity diabwtic hypertension and family history of T2DM.

Most of the male patients consumed appropriate proportions of carbohydrate However, Mcaronutrient patients did not show any significant differences of the sourcrs intake among infividuals three groups of Mactonutrient patients. The Macornutrient of Increasing nutrient bioavailability intake among T2DM patients in this study showed incividuals of carbohydrate and protein within the range of Malaysian RNI, coupled with Airway inflammation fat intake.

Sourcrs with the Recommended Nutrient Intake RNI was Coconut water hydration for both Substance abuse recovery and protein but not for fat. The pattern indicated a preference for fat rather than protein Mushroom Soup Recipes carbohydrate intake was restricted.

Peer Review reports. The global prevalence of diabetes Macronitrient is estimated to rise from Protein-rich foods for muscle recovery. The prevalence of T2DM has been escalating indkviduals in developing countries such as Malaysia [ 3 ].

The National Health and Morbidity Surveys NMHS in Malaysia reported Macrontrient increase in T2DM prevalence from Meanwhile, the Indivlduals also reported that the prevalence of newly diagnosed T2DM cases amongst those idabetic known to Macronutrient sources for diabetic individuals T2DM in Malaysia increased from indivjduals.

Macronutrient sources for diabetic individuals group has the same risk of developing complications of diabetes as already-diagnosed T2DM patients.

Newly Body fat estimation T2DM patients are more prone to undividuals T2DM complications at a later stage due to uncontrolled glucose levels [ 6 ].

T2DM is associated with both unmodifiable factors age and genetics and indiviiduals risk factors sourcew and dietary intake [ 1 ]. Modification Yoga and meditation for recovery dietary intake duabetic key to sourcs the prevention and treatment kndividuals T2DM diabetif 7 ].

Ofr Nutrition Division of the Ministry of Macronutriwnt, Malaysia, has been indjviduals healthy indiviiduals practices among the Inddividuals population diabetc facilitate a higher quality individualz life.

These Macronutrient sources for diabetic individuals were derivatives of the Herbal weight loss oil guideline provided by the Malaysian Recommended Nutrient Intake RNI. In general, Macronutrient sources for diabetic individuals, there is none sougces guidelines spurces macronutrients intake among T2DM patients.

Besides, dietary patterns such as the Mediterranean diet or Dietary Energy boosters for increased motivation to Stop Hypertension DASH diet, are beneficial in managing diabetes [ 14 ].

Although Macroutrient was evidence showing dietary factors in the development and Mactonutrient of T2DM, studies regarding dietary pattern individjals diabetes Essential vitamins for aging and management in Malaysia is fir lacking.

Studies have previously been conducted in different settings to assess the dietary intake of T2DM patients in Malaysia [ 1516Macronutrient sources for diabetic individuals ]. However, these studies did not individuas dietary intake among newly diagnosed T2DM patients.

Therefore, this study aimed to investigate the pattern of macronutrient carbohydrate, protein and fat intake among Malaysian adults with newly diagnosed and already-diagnosed T2DM.

Ineividuals PURE study fpr been described in previous literature [ daibetic1920 Macroonutrient. It indiiduals a large-scale, international study of the incidence, mortality and risk factors associated with non-communicable diseases, which includes individuals from urban and rural communities in 21 countries, including Malaysia.

The PURE study is coordinated by the Population Health Research Institute PHRIHamilton, Ontario, Canada. The Malaysian arm of the study is coordinated by two public universities, namely Universiti Kebangsaan Malaysia UKM and Universiti Teknologi MARA UiTM.

This study has enrolled 15, Malaysian individuals sinceand follow-up data collection is ongoing until Participants were recruited from selected urban and rural areas of Malaysia that represent the heterogeneity of the national population in terms of social and economic factors. Participants were recruited based on purposive sampling.

Sampling was executed by reaching out to the community leaders of the purposively selected study locations, which included all 14 states of Malaysia.

Once agreement from the community leaders was obtained, a health screening program was implemented. Prior to recruitment, individuals from the community health screening program were asked about their interest in participating in the study.

Interested individuals were followed up through home visits. Written informed consent was obtained after participants understood the provided study information and their rights as study participants. To ensure standardised methods of data collection, research assistants were trained with comprehensive operation manuals, videos and workshops.

Data were transferred electronically to the project office and coordinating centre at PHRI for quality control. The non-fasting blood sugar test was carried out for participants who did not fast prior to blood collection. Participants were defined as newly diagnosed if they had never been diagnosed with T2DM but had an elevated blood glucose level at the baseline study.

The grouping was based on the number of years from diagnosis to the time of baseline data collection. Participants reported the usual portion size of each food item in the FFQ and the average frequency of consumption.

Then, macronutrients in terms of total energy, carbohydrate, protein and fat intake were calculated based on the Malaysian food composition and US Department of Agriculture food composition databases, with reference to nutrient databases containing the recipes of mixed dishes [ 23 ].

Participant dietary intake was stratified into three groups according to the RNI for Malaysians [ 9 ]. Information on demographics, personal and family medical history, and active or passive smoking status was extracted from the validated PURE questionnaire and physical activity levels were assessed using the International Physical Activity Questionnaire IPAQ [ 192324 ].

Demographic characteristics included age rounded to the nearest year of birthgender, race Malay or non-Malaymarital status single, married or divorcededucation level none, primary, secondary or tertiary and employment status yes or no.

The residency area urban or rural was based on local government-gazetted areas. Rural areas were defined as areas occupied by less than residents per square kilometre. Height and weight were measured using a portable stature meter and the TANITA BC Ironman® segmental body composition analyser, respectively.

Body mass index BMI was derived by dividing weight by height squared. The participants were asked whether they had been diagnosed with hypertension as comorbidity.

Family medical history of T2DM and hypertension was defined as the occurrence of these comorbidities in at least one family member father, mother or siblings as reported by the participant. Active smoking status was categorised into current smokers and former tobacco smokers who had quit within the previous year, while inactive smoker was those who had never smoked.

Passive smokers included those who had been exposed to environmental tobacco smoke at least once a week for the previous year.

The data were analysed using SPSS version Chi-square test was used to assess differences in the T2DM groups stratified by gender according to the following variables: carbohydrate intake, protein intake, fat intake, age, BMI, race, marital status, education level, employment status, residency, participant comorbidities, family history of comorbidities, smoking status and physical activity level.

A total of 15, participants completed the personal medical history assessment of T2DM. Of these, participants were diagnosed with T2DM without missing data on years of being diagnosed, age, gender and obesity. Finally, a total of participants completed the FFQs.

Table 1 shows the general characteristics of this study population stratified by gender. Among male, there were significant differences among the three groups of T2DM patients according to the following variables: age, BMI, residency, participant comorbidity of hypertension, family history of T2DM and hypertension, and active smoker.

Meanwhile, female shows significant differences among the three groups of T2DM patients according to the following variables: age, BMI, marital status, education level, residency, participant comorbidity of hypertension and family history of T2DM. The Chi-square analysis showed that there were significant differences in carbohydrate and protein intake by male among the three groups of T2DM patients Table 2.

Similar trend were observed for obese patients with percentage of A study done by Mafauzy et al. To achieve this goal, medical nutrition therapy MNT was provided via individualised nutritional recommendations for T2DM patients with obesity [ 29 ].

Although overweight and obesity are well-known risk factors for type 2 diabetes, the disease also noticeable among newly diagnosed T2DM patients with normal BMI in this study male: 77, According to Gujral et al. Increased comorbidities would increase the risk of complications such as cardiovascular disease and impact the management of comorbidities, long-term survival and the health care system [ 6 ].

Other than that, family history of diabetes also shows similar trends. This is because comorbidities are heritable [ 31 ]. The results of the present study also showed that active smoking status among male participants was significantly related to T2DM.

Smoking behaviours have been reported as risk factors contributing to T2DM [ 32 ]. The Chi-square analysis showed significant differences among the three groups of T2DM patients in terms of carbohydrate and protein intake by male patients.

In addition, very few T2DM patients consumed protein in amounts less than the recommended proportions. A previous study conducted at the outpatient clinic of the University of Malaya Medical Centre reported that the mean proportions of carbohydrate, protein and fat consumed by T2DM patients were Another study by Chin et al.

found that the mean proportions of carbohydrate, protein and fat consumed by T2DM patients were Meanwhile, this study shows that the mean proportions of carbohydrate, protein and fat intake among T2DM patients were The present study found that the mean carbohydrate intake among T2DM patients was lower than in previous studies Conversely, the mean intake of protein The mean proportions of macronutrients consumed by participants in this study were found to be within the range recommended in the clinical practice guidelines for the nutritional management of T2DM patients [ 12 ].

Overall, the results of this study showed that T2DM patients mainly consumed carbohydrate and protein within the range of recommended nutrient intakes RNI for Malaysia but had a high fat intake Table 2. This pattern contradicted a review by Hussein et al. The differences may be because the former study included only already known T2DM patients, while this study included both newly diagnosed and already-diagnosed T2DM categories.

Several studies have highlighted that the general dietary intake recommendations based on macronutrients were not easily followed by both the general population and T2DM patients [ 7143334 ].

Furthermore, previous reviews have stated that the effectiveness of the existing guidelines, which set goals based on macronutrient quantity, was still equivocal in efforts to reduce the risk of T2DM [ 3334 ].

Thus, the Malaysian Ministry of Health MOH has been implementing MNT to provide individualised nutritional recommendations based on personal preferences to manage the dietary intake of T2DM patients [ 31 ].

: Macronutrient sources for diabetic individuals

How Much Fat Can People with Diabetes Have?

Diabetes care involves monitoring risk factors for both macrovascular and microvascular complications and therefore the sample size needed to detect multiple biologically and clinically relevant effect sizes requires special consideration. Furthermore, the duration of follow-up needs to be adequate relative to the outcomes of interest, and strategies should be used to improve retention.

Study design and statistical analyses should consider time-varying factors, such as changes in weight and medications, which may independently impact study outcomes, especially in small-scale efficacy trials.

Finally, due to the large volume and variety of research regarding diet and diabetes-related health outcomes, rigorous systematic reviews and meta-analyses need to be conducted so that researchers, clinicians, patients, and funding agencies are aware of the most recent research and the direction in which it is heading.

has reported being a member of the Research Committee for the American Pistachio Growers. No other potential conflicts of interest relevant to this article were reported.

researched data, contributed to discussion, and wrote, reviewed, and edited the manuscript. contributed to discussion and wrote, reviewed, and edited the manuscript.

reviewed and edited the manuscript. researched data, contributed to discussion, and reviewed and edited the manuscript. The authors thank M. Sue Kirkman, MD, for her input into the manuscript and the former University of North Carolina students for conducting the initial literature search: Emily Ford, MPH, RD; Natalie Peterson, MPH, RD; Cassandra Rico, MPH, RD; Carolyn Wait, MPH, RD; and John Yoon, BS.

Sign In or Create an Account. Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care.

Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 35, Issue 2. Previous Article Next Article. Systematic review procedure. Challenges in evaluating macronutrient studies in diabetes management. Question 1: What aspects of macronutrient quantity and quality impact glycemic control and CVD risk in people with diabetes?

Carbohydrate amount. Carbohydrate type. Fat amount. Fat type. Question 2A: How do macronutrients combine in food groups to affect glycemic response and CVD risk reduction in people with diabetes?

Whole grains. Vegetables and fruit. Meats, poultry, and fish. Question 2B: How do macronutrients combine in eating patterns to affect glycemic response and CVD risk factors in people with diabetes?

Vegetarian eating pattern. Question 3: Is there an optimal macronutrient ratio for glycemic management and cardiovascular risk reduction in people with diabetes? Question 4: What should guide the future directions of research? Article Navigation. Systematic Review January 16 Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes : A systematic review of the literature, Madelyn L.

Wheeler, MS ; Madelyn L. Wheeler, MS. This Site. Google Scholar. Stephanie A. Dunbar, MPH ; Stephanie A. Dunbar, MPH. Corresponding author: Stephanie A. Dunbar, sdunbar diabetes. Lindsay M. Jaacks, BS ; Lindsay M.

Jaacks, BS. Wahida Karmally, DRPH ; Wahida Karmally, DRPH. Elizabeth J. Mayer-Davis, MSPH ; Elizabeth J. Mayer-Davis, MSPH. Judith Wylie-Rosett, EDD ; Judith Wylie-Rosett, EDD. William S. Yancy, Jr. Diabetes Care ;35 2 — Get Permissions. toolbar search Search Dropdown Menu.

toolbar search search input Search input auto suggest. What findings and needs should direct future research? Evidence-based nutrition practice guidelines for diabetes and scope and standards of practice.

Search ADS. American Dietetic Association. Diabetes type 1 and 2 evidence-based nutrition practice guidelines for adults [article online], Chicago, IL. Accessed 10 November The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults.

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.

Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. UKPDS estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy.

Action for Health in Diabetes Look AHEAD trial: baseline evaluation of selected nutrients and food group intake. Trends in nutrient intake among adults with diabetes in the United States: Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes.

Short-term effects of severe dietary carbohydrate-restriction advice in type 2 diabetes—a randomized controlled trial. Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes.

A low-carbohydrate diet is more effective in reducing body weight than healthy eating in both diabetic and non-diabetic subjects. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial.

The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus.

Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.

The Canadian Trial of Carbohydrates in Diabetes CCD , a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.

Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study. A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, wk clinical trial. Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes.

A high-protein diet with resistance exercise training improves weight loss and body composition in overweight and obese patients with type 2 diabetes.

Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes.

Comparison of a high-carbohydrate and a high-monounsaturated fat, olive oil-rich diet on the susceptibility of LDL to oxidative modification in subjects with type 2 diabetes mellitus.

Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis.

Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. A low-fat diet improves peripheral insulin sensitivity in patients with type 1 diabetes. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes.

Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Improved plasma glucose control, whole-body glucose utilization, and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial.

A flexible, low-glycemic index Mexican-style diet in overweight and obese subjects with type 2 diabetes improves metabolic parameters during a 6-week treatment period. The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control.

Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. A randomized clinical trial comparing low-glycemic index versus ADA dietary education among individuals with type 2 diabetes.

The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes. Low-glycemic index carbohydrates: an effective behavioral change for glycemic control and weight management in patients with type 1 and 2 diabetes.

The First Step First Bite Program: guidance to increase physical activity and daily intake of low-glycemic index foods. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence.

Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids macronutrients.

Washington, DC, The National Academies Presses, , p. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. Long-term use of a diabetes-specific oral nutritional supplement results in a low-postprandial glucose response in diabetes patients.

Arabinoxylan fibre improves metabolic control in people with type II diabetes. Supplementation of conventional therapy with the novel grain Salba Salvia hispanica L. improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial.

Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Effects of Cassia tora fiber supplement on serum lipids in Korean diabetic patients. Effects of native banana starch supplementation on body weight and insulin sensitivity in obese type 2 diabetics.

De Natale. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes.

Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Intake of soluble fibers has a protective role for the presence of metabolic syndrome in patients with type 2 diabetes. Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus.

Effects of a 3-day low-fat diet on metabolic control, insulin sensitivity, lipids and adipocyte hormones in Norwegian subjects with hypertriacylglycerolaemia and type 2 diabetes. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—Lifestyle Over and Above Drugs in Diabetes LOADD study: randomised controlled trial.

Liquid meal replacements and glycemic control in obese type 2 diabetes patients. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein.

Adults with type 1 diabetes eat a high-fat atherogenic diet that is associated with coronary artery calcium. Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes.

Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension.

Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes.

The efficacy of omega-3 fatty acid supplementation on plasma homocysteine and malondialdehyde levels of type 2 diabetic patients. Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes. Effect of fish oil versus corn oil supplementation on LDL and HDL subclasses in type 2 diabetic patients.

Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Effects of omega-3 fatty acid supplements on serum lipids, apolipoproteins and malondialdehyde in type 2 diabetes patients.

Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. This reference was withdrawn. Look AHEAD Action for Health in Diabetes Obesity, Inflammation, and Thrombosis Research Group.

Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD Action for Health in Diabetes study. Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes.

Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy.

A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy. Studies of vegetarian or vegan eating plans ranged in duration from 12 to 74 weeks and showed mixed results on glycemia and CVD risk factors.

These eating plans often resulted in weight loss 92 — Two meta-analyses of controlled trials 98 , 99 concluded that vegetarian and vegan eating plans can reduce A1C by an average of 0. In the Look AHEAD Action for Health in Diabetes trial , individuals following a calorie-restricted low-fat eating pattern, in the context of a structured weight loss program using meal replacements, achieved moderate success compared with the control condition eating plan However, lowering total fat intake did not consistently improve glycemia or CVD risk factors in people with type 2 diabetes based on a systematic review 45 , several studies — , and a meta-analysis Benefit from a low-fat eating pattern appears to be mostly related to weight loss as opposed to the eating pattern itself , The Ornish and Pritikin lifestyle programs are two of the best known multicomponent very low-fat eating patterns.

Three nonrandomized single-arm studies with 69 to participants lasting between 3 weeks and 2—3 years show that these multicomponent lifestyle intervention programs may improve glucose levels, weight, blood pressure, and HDL-C, with a mixed effect on triglycerides — Low-carbohydrate eating patterns, especially very low-carbohydrate VLC eating patterns, have been shown to reduce A1C and the need for antihyperglycemic medications.

These eating patterns are among the most studied eating patterns for type 2 diabetes. In trials up to 6 months long, the low-carbohydrate eating pattern improved A1C more, and in trials of varying lengths, lowered triglycerides, raised HDL-C, lowered blood pressure, and resulted in greater reductions in diabetes medication Finally, in another meta-analysis comparing low-carbohydrate to high-carbohydrate eating patterns, the larger the carbohydrate restriction, the greater the reduction in A1C, though A1C was similar at durations of 1 year and longer for both eating patterns Table 4 provides a quick reference conversion of percentage of calories from carbohydrate to grams of carbohydrate based on number of calories consumed per day.

Quick reference conversion of percent calories from carbohydrate shown in grams per day as reported in the research reviewed for this report. Because of theoretical concerns regarding use of VLC eating plans in people with chronic kidney disease, disordered eating patterns, and women who are pregnant, further research is needed before recommendations can be made for these subgroups.

Adopting a VLC eating plan can cause diuresis and swiftly reduce blood glucose; therefore, consultation with a knowledgeable practitioner at the onset is necessary to prevent dehydration and reduce insulin and hypoglycemic medications to prevent hypoglycemia. No randomized trials were found in people with type 2 diabetes that varied the saturated fat content of the low- or very low-carbohydrate eating patterns to examine effects on glycemia, CVD risk factors, or clinical events.

Most of the trials using a carbohydrate-restricted eating pattern did not restrict saturated fat; from the current evidence, this eating pattern does not appear to increase overall cardiovascular risk, but long-term studies with clinical event outcomes are needed — One small, 8-week study comparing the DASH eating pattern with a control group in people with type 2 diabetes indicated improved A1C, blood pressure, and cholesterol levels and weight loss with the DASH eating pattern, with no difference in triglycerides Another RCT compared the DASH eating pattern incorporating increased physical activity with a standard eating pattern without increased physical activity and found blood pressure was lower in the DASH and physical activity group, but A1C, weight, and lipids did not differ Research studies focused on a paleo eating pattern in adults with type 2 diabetes are small and few, ranging from 13—29 participants, lasting no longer than 3 months, and finding mixed effects on A1C, weight, and lipids — While intermittent fasting is not an eating pattern by definition, it has been included in this discussion because of increased interest from the diabetes community.

Fasting means to go without food, drink, or both for a period of time. People fast for reasons ranging from weight management to upcoming medical visits to religious and spiritual practice. Intermittent fasting is a way of eating that focuses more on when you eat i.

While it usually involves set times for eating and set times for fasting, people can approach intermittent fasting in many different ways.

Published intermittent fasting studies involving diabetes and diabetes prevention demonstrate a variety of approaches, including restricting food intake for 18 to 20 h per day, alternate-day fasting, and severe calorie restriction for up to 8 consecutive days or longer Three of the studies — demonstrated that intermittent fasting, either in consecutive days of restriction or by fasting 16 h per day or more, may result in weight loss; however, there was no improvement in A1C compared with a nonfasting eating plan.

One of the studies showed similar reductions in A1C, weight, and medication doses when 2 days of severe energy restriction were compared with chronic energy restriction. Another study looked at men with prediabetes and timing of food intake over a h period, with the intervention group restricted to a 6-h schedule of eating with final meal before 3 p.

compared with a control schedule where eating occurred over a h period; improved insulin sensitivity, β-cell responsiveness, blood pressure, oxidative stress, and appetite were shown in the intervention group The safety of intermittent fasting in people with special health situations, including pregnancy and disordered eating, has not been studied.

For adults with type 1 diabetes, no trials met the inclusion criteria for this Consensus Report related to Mediterranean-style, vegetarian or vegan, low-fat, low-carbohydrate, DASH, paleo, Ornish, or Pritikin eating patterns.

A few studies have examined the impact of a VLC eating pattern for adults with type 1 diabetes. One randomized crossover trial with 10 participants examined a VLC eating pattern aiming for 47 g carbohydrate per day without a focus on calorie restriction compared with a higher carbohydrate eating pattern aiming for g carbohydrate per day for 1 week each.

Participants following the VLC eating pattern had less glycemic variability, spent more time in euglycemia and less time in hypoglycemia, and required less insulin A single-arm person trial of a VLC eating pattern aimed at a goal of 75 g of carbohydrate or less per day found that weight, A1C, and triglycerides were reduced and HDL-C increased after 3 months, and after 4 years A1C was still lower and HDL-C was still higher than at baseline This evidence suggests that a VLC eating pattern may have potential benefits for adults with type 1 diabetes, but clinical trials of sufficient size and duration are needed to confirm prior findings.

Until the evidence surrounding comparative benefits of different eating patterns in specific individuals strengthens, health care providers should focus on the key factors that are common among the patterns: 1 emphasize nonstarchy vegetables, 2 minimize added sugars and refined grains, and 3 choose whole foods over highly processed foods to the extent possible Multiple trials and meta-analyses have been published addressing the comparative effects of specific eating patterns for diabetes.

Whereas no single eating pattern has emerged as being clearly superior to all others for all diabetes-related outcomes, evidence suggests certain eating patterns are better for specific outcomes. All eating patterns include a range of more-healthy versus less-healthy options: lentils and sugar-sweetened beverages are both considered part of a vegan eating pattern; fish and processed red meats are both considered part of a low-carbohydrate eating pattern; and removing the bun from a fast food burger might make it part of a paleo eating pattern but does not necessarily make it healthier.

For adults with type 2 diabetes who are not taking insulin and who have limited health literacy or numeracy, or who are older and prone to hypoglycemia, a simple and effective approach to glycemia and weight management emphasizing appropriate portion sizes and healthy eating may be considered.

People with prediabetes at a healthy weight should be considered for lifestyle intervention involving both aerobic and resistance exercise and a healthy eating plan such as a Mediterranean-style eating plan.

People with diabetes and prediabetes should be screened and evaluated during DSMES and MNT encounters for disordered eating, and nutrition therapy should accommodate these disorders. There is substantial evidence indicating that weight loss is highly effective in preventing progression from prediabetes to type 2 diabetes and in managing cardiometabolic health in type 2 diabetes.

Overweight and obesity are also increasingly prevalent in people with type 1 diabetes and present clinical challenges regarding diabetes treatment and CVD risk factors , Regular physical activity, which can contribute to both weight loss and prevention of weight regain, and behavioral strategies are also important components of lifestyle therapy for weight management 26 , 74 , 83 , — Structured weight loss programs with regular visits and use of meal replacements have been shown to enhance weight loss in people with diabetes — The combined data do not point to a threshold of weight loss for maximal clinical benefits in people with diabetes; rather, the greater the weight loss, the greater the benefits.

The UK Prospective Diabetes Study UKPDS demonstrated that decreases in fasting glucose were correlated with degree of weight loss A meta-analysis conducted by Franz et al. Other meta-analyses focusing on nonmedicine or medicine-assisted weight loss interventions in type 2 diabetes support this finding — More recently, the Look AHEAD trial , compared standard DSMES to a more intensive lifestyle intervention and reduced-calorie eating plan.

The intensive lifestyle intervention resulted in 8. A systematic review of the effectiveness of MNT revealed mixed weight loss outcomes in participants with type 1 and 2 diabetes 9. Similarly, while DSMES is a fundamental component of diabetes care 1 , it does not consistently produce sufficient weight loss to achieve optimal therapeutic benefits in people with diabetes , , For these reasons, diabetes MNT and DSMES should emphasize a targeted and concerted plan for weight management.

The addition of metabolic surgery , weight loss medications , and glucose-lowering agents that promote weight loss can also be used as an adjunct to lifestyle interventions, resulting in greater weight loss that is maintained for a longer period of time. The data also support the position that weight loss therapy is effective at all phases of type 2 diabetes, both in individuals with recent-onset disease 1 , and in people with longer durations of diabetes treated with multiple diabetes medications , Regular physical activity by itself , or as part of a comprehensive lifestyle plan 26 , 74 , 83 , can prevent progression to type 2 diabetes in high-risk individuals.

Studies have demonstrated beneficial effects of both aerobic and resistance exercise and additive benefits when both forms of exercise are combined — For purposes of weight loss, the ability to sustain and maintain an eating plan that results in an energy deficit, irrespective of macronutrient composition or eating pattern, is critical for success — Studies investigating specific weight loss eating plans using a broad range of macronutrient composition in people with diabetes have shown mixed results regarding effects on weight, A1C, serum lipids, and blood pressure , , , — As a result, the evidence does not identify one eating plan that is clearly superior to others and that can be generally recommended for weight loss for people with diabetes Individualized eating plans should support calorie reduction e.

Weight loss interventions can be implemented in usual care settings and alternately in telehealth programs , In general, the intervention intensity and degree of individual participation in the program are important factors for successful weight loss — , The Look AHEAD trial and the Diabetes Remission Clinical Trial DiRECT highlight the potential for type 2 diabetes remission—defined as the maintenance of euglycemia complete remission or prediabetes level of glycemia partial remission with no diabetes medication for at least 1 year , —in people undergoing weight loss treatment.

In the Look AHEAD trial, when compared with the control group, the intensive lifestyle arm resulted in at least partial diabetes remission in Diet composition may also play a role; in an RCT by Esposito et al. Obesity prevalence among people with type 1 diabetes has been significantly increasing — A recent study suggested obesity may promote progression to overt type 1 diabetes in at-risk individuals , but further confirmatory studies are needed.

In addition, in people with established type 1 diabetes, presence of obesity can worsen insulin resistance, glycemic variability, microvascular disease complications, and cardiovascular risk factors — Therefore, weight management has been recommended as an essential component of care for people with type 1 diabetes who have overweight or obesity — There is a scarcity of evidence from RCTs evaluating weight loss interventions in type 1 diabetes.

A retrospective nested-control study indicated that lifestyle-induced weight loss improved glycemia with a reduction in insulin doses compared with controls Individuals with type 1 diabetes and obesity may benefit from eating plans that result in an energy deficit and that are lower in total carbohydrate and GI and higher in fiber and lean protein Currently, adjunctive pharmacotherapy is not indicated for individuals with type 1 diabetes.

However, there is preliminary evidence that in select individuals with type 1 diabetes and excess adiposity, newer pharmacotherapy i. In addition, metabolic surgery in appropriate candidates can decrease body weight and improve glycemia , When counseling individuals with diabetes and prediabetes about weight management, special attention also must be given to prevent, diagnose, and treat disordered eating.

Disordered eating can make following an eating plan challenging Health care professionals should consider screening for disordered eating, refer to a mental health professional, and individualize nutrition therapy accordingly When sugar substitutes are used to reduce overall calorie and carbohydrate intake, people should be counseled to avoid compensating with intake of additional calories from other food sources.

SSB consumption in the general population contributes to a significantly increased risk of type 2 diabetes, weight gain, heart disease, kidney disease, nonalcoholic liver disease, and tooth decay The U. Food and Drug Administration FDA has reviewed several types of sugar substitutes for safety and approved them for consumption by the general public, including people with diabetes In this report, the term sugar substitutes refers to high-intensity sweeteners, artificial sweeteners, nonnutritive sweeteners, and low-calorie sweeteners.

These include saccharin, neotame, acesulfame-K, aspartame, sucralose, advantame, stevia, and luo han guo or monk fruit. Replacing added sugars with sugar substitutes could decrease daily intake of carbohydrates and calories.

These dietary changes could beneficially affect glycemic, weight, and cardiometabolic control. However, an American Heart Association science advisory on the consumption of beverages containing sugar substitutes that was supported by the ADA concluded there is not enough evidence to determine whether sugar substitute use definitively leads to long-term reduction in body weight or cardiometabolic risk factors, including glycemia Using sugar substitutes does not make an unhealthy choice healthy; rather, it makes such a choice less unhealthy.

If sugar substitutes are used to replace caloric sweeteners, without caloric compensation, they may be useful in reducing caloric and carbohydrate intake , although further research is needed to confirm these concepts Multiple mechanisms have been proposed for potential adverse effects of sugar substitutes, e.

As people aim to reduce their intake of SSBs, the use of other alternatives, with a focus on water, is encouraged Sugar alcohols represent a separate category of sweeteners. Like sugar substitutes, sugar alcohols have been approved by the FDA for consumption by the general public and people with diabetes.

Whereas sugar alcohols have fewer calories per gram than sugars, they are not as sweet. Therefore, a higher amount is required to match the degree of sweetness of sugars, generally bringing the calorie content to a level similar to that of sugars Use of sugar alcohols needs to be balanced with their potential to cause gastrointestinal effects in sensitive individuals.

Currently, there is little research on the potential benefits of sugar alcohols for people with diabetes It is recommended that adults with diabetes or prediabetes who drink alcohol do so in moderation one drink or less per day for adult women and two drinks or less per day for adult men.

Educating people with diabetes about the signs, symptoms, and self-management of delayed hypoglycemia after drinking alcohol, especially when using insulin or insulin secretagogues, is recommended.

The importance of glucose monitoring after drinking alcohol beverages to reduce hypoglycemia risk should be emphasized. It is important that health care providers counsel people with diabetes about alcohol consumption and encourage moderate and sensible use for people choosing to consume alcohol.

One alcohol-containing beverage is defined as oz beer, 5-oz wine, or 1. Starting with one drink per day, risk for reduced adherence to self-care and healthy lifestyle behaviors has been reported with increasing alcohol consumption Despite the potential glycemic and cardiovascular benefits of moderate alcohol consumption, alcohol intake may place people with diabetes at increased risk for delayed hypoglycemia , — This is particularly relevant for those using insulin or insulin secretagogues who can experience delayed nocturnal or fasting hypoglycemia after evening alcohol consumption.

Consuming alcohol with food can minimize the risk of nocturnal hypoglycemia , It is essential that people with diabetes receive education regarding the recognition and management of delayed hypoglycemia and the potential need for more frequent glucose monitoring after consuming alcohol , Comprehensive reviews and meta-analyses suggest a protective effect of moderate alcohol intake on the risk of developing type 2 diabetes, with a higher rate of diabetes in alcohol abstainers and heavy consumers , — Knott et al.

A meta-analysis and systematic review that examined the effects of specific types of alcohol beverage consumption and the incidence of type 2 diabetes found that wine consumption was associated with significantly lower diabetes risk, as compared with a smaller reduction in risk with beer and spirits.

While epidemiologic evidence shows a correlation between alcohol consumption and risk of diabetes, the evidence does not suggest that providers should advise abstainers to start consuming alcohol. Without underlying deficiency, the benefits of multivitamins or mineral supplements on glycemia for people with diabetes or prediabetes have not been supported by evidence, and therefore routine use is not recommended.

It is recommended that MNT for people taking metformin include an annual assessment of vitamin B12 status with guidance on supplementation options if deficiency is present.

The routine use of chromium or vitamin D micronutrient supplements or any herbal supplements, including cinnamon, curcumin, or aloe vera, for improving glycemia in people with diabetes is not supported by evidence and is therefore not recommended.

Scientific evidence does not support the use of dietary supplements in the form of vitamins or minerals to meet glycemic targets or improve CVD risk factors in people with diabetes or prediabetes, in the absence of an underlying deficiency — People with diabetes not achieving glucose targets may have an increased risk of micronutrient deficiencies , so maintaining a balanced intake of food sources that provide at least the recommended daily allowance for nutrients and micronutrients is essential For special populations, including women planning pregnancy, people with celiac disease, older adults, vegetarians, and people following an eating plan that restricts overall calories or one or more macronutrients, a multivitamin supplement may be justified A systematic review on the effect of chromium supplementation on glucose and lipid metabolism concluded that evidence is limited by poor study quality and heterogeneity in methodology and results , Evidence from clinical studies that evaluated magnesium , and vitamin D — supplementation to improve glycemia in people with diabetes is likewise conflicting.

However, evidence is emerging that suggests that magnesium status may be related to diabetes risk in people with prediabetes It is important to consider that nutritional supplements and herbal products are not standardized or regulated , Health care providers should ask about the use of supplements and herbal products, and providers and people with or at risk for diabetes should discuss the potential benefit of these products weighed against the cost and possible adverse effects and drug interactions.

The variability of herbal and micronutrient supplements makes research in this area challenging and makes it difficult to conclude effectiveness. To date, there is limited evidence supporting the addition of herbal supplements to manage glycemia.

Because of public interest and the lack of conclusive data, the National Center for Complementary and Integrative Health at the National Institutes of Health aims to answer important public health and scientific questions by funding and conducting research on complementary medicine.

Metformin is associated with vitamin B12 deficiency, with a recent systematic review recommending that annual blood testing of vitamin B12 levels be considered in metformin-treated people, especially in those with anemia or peripheral neuropathy This study found that even in the absence of anemia, B12 deficiency was prevalent.

The exact cause of B12 deficiency in people taking metformin is not known, but some research points to malabsorption caused by metformin, with other studies suggesting improvements in B12 status with calcium supplementation — The standard of treatment has been B12 injections, but new research suggest that high-dose oral supplementation may be as effective , More research is needed in this area.

All RDNs providing MNT in diabetes care should assess and monitor medication changes in relation to the nutrition care plan.

For individuals with type 1 diabetes, intensive insulin therapy using the carbohydrate counting approach can result in improved glycemia and is recommended.

For adults using fixed daily insulin doses, consistent carbohydrate intake with respect to time and amount, while considering the insulin action time, can result in improved glycemia and reduce the risk for hypoglycemia.

A cautious approach to increasing mealtime insulin doses is suggested; continuous glucose monitoring CGM or self-monitoring of blood glucose SMBG should guide decision-making for administration of additional insulin. RDNs providing MNT in diabetes care should assess and monitor medication changes in relation to the nutrition care plan.

Along with other diabetes care providers, RDNs who possess advanced practice training and clinical expertise should take an active role in facilitating and maintaining organization-approved diabetes medication protocols.

For people with type 1 diabetes using basal-bolus insulin therapy, a primary focus for MNT should include guidance on adjusting insulin based on anticipated dietary intake, particularly carbohydrate intake 9 , — ; recent or expected physical activity; and glucose data. Intensive insulin management education programs that include nutrition therapy have been shown to improve A1C 9 , , , — and quality of life 9 , For people using fixed daily insulin doses, carbohydrate intake on a day-to-day basis should be consistent with respect to time and amount per meal 9 , , Checking glucose 3 h after eating may help to determine if additional insulin adjustments i.

Because these insulin dosing algorithms require determination of anticipated nutrient intake to calculate the mealtime dose, health literacy and numeracy should be evaluated.

The effectiveness of insulin dosing decisions should be confirmed with a structured approach to SMBG or CGM to evaluate individual responses and guide insulin dose adjustments. In general, replacing saturated fat with unsaturated fats reduces both total cholesterol and LDL-C and also benefits CVD risk.

In type 2 diabetes, counseling people on eating patterns that replace foods high in carbohydrate with foods lower in carbohydrate and higher in fat may improve glycemia, triglycerides, and HDL-C; emphasizing foods higher in unsaturated fat instead of saturated fat may additionally improve LDL-C.

The recommendation for the general public to eat a serving of fish particularly fatty fish at least two times per week is also appropriate for people with diabetes. Nutrition therapy that includes the development of an eating plan designed to optimize blood glucose trends, blood pressure, and lipid profiles is important in the management of diabetes and can lower the risk of CVD, CHD, and stroke 9.

Findings from clinical trials support the role of nutrition therapy for achieving glycemic targets and decreasing various markers of cardiovascular and hypertension risk 9 , 24 , — There has been increasing research examining the effects of high-fat, low-carbohydrate eating patterns on cardiometabolic risk factors, with two systematic reviews showing benefits of low-carbohydrate eating plans compared with low-fat eating plans on glycemic and CVD risk parameters in the treatment of type 2 diabetes see the section Low-Carbohydrate or Very Low-Carbohydrate Eating Patterns , The scientific rationale for decreasing saturated fat in the diet is based on the effect of saturated fat in raising LDL-C, a contributing factor in atherosclerosis In a Presidential Advisory on dietary fat and CVD, the American Heart Association concluded that lowering intake of saturated fat and replacing it with unsaturated fats, especially polyunsaturated fats, will lower the incidence of CVD Subgrouping of the studies suggested that benefit occurred by replacing saturated fat with polyunsaturated fat but not with carbohydrate or protein In a systematic review of observational studies, saturated fats were not associated with all-cause mortality, CVD, CHD, ischemic stroke, or type 2 diabetes, but limitations common to observational studies were noted The replacement of saturated fat with monounsaturated or polyunsaturated fat in food or replacement of trans fat with monounsaturated fat in food was inversely associated with CVD In general, replacing saturated fat with unsaturated fats, especially polyunsaturated fat, significantly reduces both total cholesterol and LDL-C, and replacement with monounsaturated fat from plant sources, such as olive oil and nuts, reduces CVD risk.

Replacing saturated fat with carbohydrate also reduces total cholesterol and LDL-C, but significantly increases triglycerides and reduces HDL-C , A recent meta-analysis of nine RCTs showed that, compared with control, the Mediterranean-style eating pattern, which is high in monounsaturated fats from plant sources such as olive oil and nuts, improved outcomes of glycemia, body weight, and cardiovascular risk factors in participants with type 2 diabetes A systematic review and meta-analysis of 24 studies and including 1, participants compared the effect of eating plans high in monounsaturated fat with that of eating plans high in carbohydrates.

The eating plans high in monounsaturated fat showed significant reductions in fasting glucose, triglycerides, body weight, and systolic blood pressure along with significant increases in HDL-C. The systematic review and meta-analysis also reviewed four studies with a total of 44 participants comparing eating plans high in monounsaturated fat with those high in polyunsaturated fat.

The eating plans high in monounsaturated fat led to a significant reduction in fasting plasma glucose As is recommended for the general public, an increase in foods containing the long-chain omega-3 fatty acids EPA and docosahexaenoic acid DHA , such as are found in fatty fish, is recommended for individuals with diabetes because of their beneficial effects on lipoproteins, prevention of heart disease, and associations with positive health outcomes in observational studies , For people following a vegetarian or vegan eating pattern, omega-3 α-linoleic acid ALA found in plant foods such as flax, walnuts, and soy are reasonable replacements for foods high in saturated fat and may provide some CVD benefits, though the evidence is inconclusive.

Evidence does not conclusively support recommending omega-3 EPA and DHA supplements for all people with diabetes for the prevention or treatment of cardiovascular events. Omega-3 fatty acid supplements have not reduced CVD events or mortality in randomized trials but may have utility in people who require triglyceride reduction , A meta-analysis of seven RCTs showed that increased trans fat intake did not result in changes in glucose, insulin, or triglyceride concentrations but led to an increase in total and LDL-C and a decrease in HDL-C concentrations Trans fats also have been associated with all-cause mortality, total CHD, and CHD mortality Some studies measuring urine sodium excretion in people with type 1 and type 2 diabetes have shown increased mortality associated with the lowest sodium intakes.

When individualizing sodium intake recommendations, careful consideration must be given to issues such as food preference, palatability, availability, and additional cost of fresh or specialty low-sodium products In individuals with diabetes and non—dialysis-dependent diabetic kidney disease DKD , reducing the amount of dietary protein below the recommended daily allowance 0.

Historically, low-protein eating plans were advised to reduce albuminuria and progression of chronic kidney disease in people with DKD, typically with improvements in albuminuria but no clear effect on estimated glomerular filtration rate.

In addition, there is some indication that a low-protein eating plan may lead to malnutrition in individuals with DKD — The average daily level of protein intake for people with diabetes without kidney disease is typically 1—1. Evidence does not suggest that people with DKD need to restrict protein intake to less than the average protein intake.

For people with DKD and macroalbuminuria, changing to a more soy-based source of protein may improve CVD risk factors but does not appear to alter proteinuria , Correcting hyperglycemia is one strategy for the management of gastroparesis, as acute hyperglycemia delays gastric emptying.

Consultation by an RDN knowledgeable in the management of gastroparesis is helpful in setting and maintaining treatment goals Treatment goals include managing and reducing symptoms; correcting fluid, electrolyte, and nutritional deficiencies and glycemic imbalances; and addressing the precipitating cause s with appropriate drug therapy Correcting hyperglycemia is one strategy for the management of gastroparesis, as acute hyperglycemia delays gastric emptying , Modification of food and beverage intake is the primary management strategy, especially among individuals with mild symptoms.

People with gastroparesis may find it helpful to eat small, frequent meals. Replacing solid food with a greater proportion of liquid calories to meet individualized nutrition requirements may be helpful because consuming solid food in large volumes is associated with longer gastric emptying times , Large meals can also decrease the lower esophageal sphincter pressure, which may cause gastric reflux, providing further aggravation Many of the foods typically recommended for people with diabetes, such as leafy green salads, raw vegetables, beans, and fresh fruits, and other food like fatty or tough meat, can be some of the most difficult foods for the gastroparetic stomach to grind and empty , Notably, the majority of nutrition therapy interventions for gastroparesis are based on the knowledge of the pathophysiology and clinical judgment rather than empirical research The use of an insulin pump is another option for individuals with type 1 diabetes and insulin-requiring type 2 diabetes with gastroparesis A small but positive month trial reported a 1.

An insulin pump can be used to provide consistent basal insulin infusion, as well as the ability to modify mealtime insulin delivery doses as needed. The variable bolus feature allows the user to administer a portion of the meal bolus in an extended fashion over a longer period of time Use of this feature may help to decrease the risk of postprandial hyperglycemia as well as hypoglycemia.

When an individual with gastroparesis falls below target weight, nutrition support in the form of oral for acute exacerbation of symptoms , enteral, or parenteral nutrition should be considered Studies using personalized nutrition approaches to examine genetic, metabolomic, and microbiome variations have not yet identified specific factors that consistently improve outcomes in type 1 diabetes, type 2 diabetes, or prediabetes.

Currently, use of nutrition counseling approaches aimed at personalizing guidance based on genetic, metabolomic, and microbiome information is an area of intense research. Testing has become available commercially, with direct-to-consumer advertising.

Some intriguing research has shown, for example, the wide interpersonal variability in blood glucose response to standardized meals that could be predicted by clinical and microbiome profiles At this point, however, no clear conclusions can be drawn regarding their utility owing to wide variations in the markers used for predicting outcomes, in the populations and nutrients studied, and in the associations found.

Ideally, an eating plan should be developed in collaboration with the person with prediabetes or diabetes and an RDN through participation in diabetes self-management education when the diagnosis of prediabetes or diabetes is made.

Regular follow-up with a diabetes health care provider is also critical to adjust other aspects of the treatment plan as indicated. Unfortunately, national data indicate that most people with diabetes do not receive any nutrition therapy or formal diabetes education 4 , 9 , 16 , providing in-person or technology-enabled diabetes nutrition therapy and education integrated with medical management 9 , 12 , 13 , 15 , 16 , 19 , 22 , — , — ;.

engineering solutions that include two-way communication between the individual and his or her health care team to provide individualized feedback and tailored education based on the analyzed patient-generated health data 38 , , ;. increasing the use of community health workers and peer coaches to provide culturally appropriate, ongoing support and clinically linked care coordination and improve the reach of MNT and DSMES 15 , 19 , 23 , 38 , , Evaluating nutrition evidence is complex given that multiple dietary factors influence glycemic management and CVD risk factors, and the influence of a combination of factors can be substantial.

Based on a review of the evidence, it is clear that knowledge gaps continue to exist and further research on nutrition and eating patterns is needed in individuals with type 1 diabetes, type 2 diabetes, and prediabetes.

Future studies should address. the impact of different eating patterns compared with one another, controlling for supplementary advice such as stress reduction, physical activity, or smoking cessation ;.

the impact of weight loss on other outcomes which eating plans are beneficial only with weight loss, which can show benefit regardless of weight loss ;. how cultural or personal preferences, psychological supports, co-occurring conditions, socioeconomic status, food insecurity, and other factors impact being consistent with an eating plan and its effectiveness;.

the need for increased length and size of studies, to better understand long-term impacts on clinically relevant outcomes;. comparisons of different delivery methods aided by technology e.

ongoing cost-effectiveness studies that will further support coverage by third-party payers or bundling services into evolving value-based care and payment models.

The authors acknowledge Mindy Saraco Managing Director, Medical Affairs, ADA for her help with the development of the Consensus Report.

The authors acknowledge the invited peer reviewers who provided comments on an earlier draft of this report: Kelli Begay Indian Health Service, Rockville, MD , Guoxun Chen University of Tennessee, Knoxville, TN , Frank Hu Harvard T. Duality of Interest. The authors disclosed all potential financial conflicts of interest with industry.

These disclosures were discussed at the onset of the consensus statement development process. The ADA uses general revenues to fund development of its consensus reports and does not rely on industry support for these purposes.

reports honorarium from the Academy of Nutrition and Dietetics and the ADA outside of the submitted work. reports personal fees from Novo Nordisk, Merck, Amgen, Gilead, BOYDSense, the American Medical Group Association, and Janssen and grants from Sanofi, Pfizer, Merck, and Novo Nordisk outside of the submitted work.

reports personal fees from Sunstar Foundation outside of the submitted work. was previously employed by the ADA. reports grants from the National Institutes of Health and internal University of Michigan grants.

reports a consulting relationship with dietdoctor. com, which began after the Consensus Report was submitted to Diabetes Care. No other potential conflicts of interest relevant to this article were reported.

Author Contributions. All authors were responsible for drafting the Consensus Report and revising it critically for important intellectual content. All authors approved the version to be published. Sign In or Create an Account.

Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care. Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 42, Issue 5. Previous Article Next Article.

Data Sources, Searches, and Study Selection. EATING PATTERNS. MNT and Antihyperglycemic Medications Including Insulin. Article Information. Article Navigation. Continuing Evolution of Nutritional Therapy for Diabetes April 15 Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report Alison B.

Evert ; Alison B. This Site. Chicken is one of the most popular protein sources, and rightfully so. It contains all of the essential amino acids our bodies can't make on their own, it's versatile and it can be an economical choice compared to other meat options. It also provides important micronutrients, like vitamin B12 and zinc.

Breaded and fried chicken dishes should be limited on a diabetes-friendly diet. Instead, chicken dishes like Sheet-Pan Chicken Fajitas and Baked Lemon-Pepper Chicken are great options that are lower in added fat and sodium. Use limited data to select advertising.

Create profiles for personalised advertising. Use profiles to select personalised advertising. Create profiles to personalise content. Use profiles to select personalised content.

Measure advertising performance. Measure content performance. Understand audiences through statistics or combinations of data from different sources. Develop and improve services. Use limited data to select content.

List of Partners vendors. Special Diets Diabetes. By Lauren is an award-winning registered dietitian, author of three books and all-around lover of good food. Lauren Manaker M. EatingWell's Editorial Guidelines. Reviewed by Dietitian EatingWell. She is a registered dietitian with a master's in food, nutrition and sustainability.

Reviewed by Dietitian Jessica Ball, M.

Navigation Menu: Social Icons Diabetes self-management education and Macronutrient sources for diabetic individuals nutrition therapy improve patient xources a pilot study documenting the efficacy of registered dietitian nutritionist interventions Nut Snack Subscription retrospective chart review. cellulose supplements invividuals significantly improved HDL cholesterol; Macronutgient second study found Macronutrient sources for diabetic individuals a diabteic, lower-fat, and lower-GI diet versus vor lower-fiber, foor diet produced significantly lower total cholesterol, LDL cholesterol, and HDL cholesterol The position of the American Diabetes Association ADA on MNT is that each person with diabetes should receive an individualized eating plan 4. Please help update this article to reflect recent events or newly available information. In a Presidential Advisory on dietary fat and CVD, the American Heart Association concluded that lowering intake of saturated fat and replacing it with unsaturated fats, especially polyunsaturated fats, will lower the incidence of CVD Three meta-analyses 40 — 42 evaluated GI.
Fiber: The Carb That Helps You Manage Diabetes | Diabetes | CDC

Diabetes and Pregnancy Chapter Diabetes in Older People Chapter Type 2 Diabetes and Indigenous Peoples. Author Disclosures Dr. References Pastors JG,WarshawH, Daly A, et al. The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care ;— Pi-Sunyer FX, Maggio CA, McCarron DA, et al.

Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes. Diabetes Care ;—7. Franz MJ, Monk A, Barry B, et al. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: A randomized, controlled clinical trial.

J Am Diet Assoc ;— Kulkarni K, Castle G, Gregory R, et al. Nutrition practice guidelines for type 1 diabetes mellitus positively affect dietitian practices and patient outcomes.

The Diabetes Care and Education Dietetic Practice Group. J Am Diet Assoc ;—70, quiz Gaetke LM, Stuart MA, Truszczynska H. A single nutrition counseling session with a registered dietitian improves short-term clinical outcomes for rural Kentucky patients with chronic diseases.

Imai S, Kozai H, Matsuda M, et al. Intervention with delivery of diabetic meals improves glycemic control in patients with type 2 diabetes mellitus. J Clin Biochem Nutr ;— Huang MC, Hsu CC, Wang HS, et al.

Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. Diabetes Care ;—9.

Robbins JM, Thatcher GE, Webb DA, et al. Nutritionist visits, diabetes classes, and hospitalization rates and charges: The Urban Diabetes Study.

Immigration and ethnocultural diversity in Canada. Ottawa: Statistics Canada, Report No. Gougeon R, Sievenpiper JL, Jenkins D, et al. The transcultural diabetes nutrition algorithm: A Canadian perspective.

Int J Endocrinol ; Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: A systematic review of randomized controlled trials.

Ash S, Reeves MM, Yeo S, et al. Effect of intensive dietetic interventions onweight and glycaemic control in overweight men with Type II diabetes: A randomised trial. Int J Obes Relat Metab Disord ;— Vallis TM, Higgins-Bowser I, Edwards L. The role of diabetes education in maintaining lifestyle changes.

Can J Diabetes ;— Willaing I, Ladelund S, Jorgensen T, et al. Nutritional counselling in primary health care: A randomized comparison of an intervention by general practitioner or dietician. Eur J Cardiovasc Prev Rehabil ;— Wilson C, Brown T, Acton K, et al.

Effects of clinical nutrition education and educator discipline on glycemic control outcomes in the Indian health service. Diabetes Care ;—4. Brekke HK, Jansson PA, Lenner RA. Long-term 1- and 2-year effects of lifestyle intervention in type 2 diabetes relatives.

Diabetes Res Clin Pract ;— Lemon CC, Lacey K, Lohse B, et al. Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes.

Rickheim PL,Weaver TW, Flader JL, et al. Assessment of group versus individual diabetes education: A randomized study. TrentoM, Basile M, Borgo E, et al. A randomised controlled clinical trial of nurse-, dietitian- and pedagogist-led group care for the management of type 2 diabetes.

J Endocrinol Invest ;— Pérez-Escamilla R, Hromi-Fiedler A, Vega-López S, et al. Impact of peer nutrition education on dietary behaviors and health outcomes among Latinos: A systematic literature review.

J Nutr Educ Behav ;— Ralston JD, Hirsch IB, Hoath J, et al. Web-based collaborative care for type 2 diabetes: A pilot randomized trial. Marcy TR, Britton ML, Harrison D. Identification of barriers to appropriate dietary behavior in low-income patients with type 2 diabetes mellitus.

Diabetes Ther ;— Christensen NK, Terry RD, Wyatt S, et al. Quantitative assessment of dietary adherence in patients with insulin-dependent diabetes mellitus. Toeller M, Klischan A, Heitkamp G, et al. Nutritional intake of IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group.

Diabetologia ;— Glazier RH, Bajcar J, Kennie NR, et al. A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Anderson TJ, Grégoire J, Pearson GJ, et al. Can J Cardiol ;— Wing RR.

Weight loss in the management of type 2 diabetes. In: Gerstein HC, Haynes B, eds. Evidence-based diabetes. Ontario: B. C, Decker Inc. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

N Engl J Med ;— KnowlerWC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The Look Ahead Research Group, Wing RR. Long term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes: Four year results of the Look AHEAD trial.

Arch Intern Med ;— Food and Nutrition Board, Institute of Medicine of the National Academics. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

Washington: The National Academies Press, Barnard ND, Cohen J, Jenkins DJ, et al. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Kirk JK, Graves DE, Craven TE, et al.

Restricted-carbohydrate diets in patients with type 2 diabetes: A meta-analysis. Dyson P. Low carbohydrate diets and type 2 diabetes: What is the latest evidence? van Wyk HJ, Davis RE, Davies JS.

A critical review of low-carbohydrate diets in people with type 2 diabetes. Diabet Med ;— Johnston BC, Kanters S, Bandayrel K, et al.

Comparison of weight loss among named diet programs in overweight and obese adults: A meta-analysis. JAMA ;— Yabe D, Iwasaki M, Kuwata H, et al.

Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study. Diabetes Obes Metab ;— Krebs JD, Parry Strong A, Cresswell P, et al.

A randomised trial of the feasibility of a low carbohydrate diet vs standard carbohydrate counting in adults with type 1 diabetes taking body weight into account. Asia Pac J Clin Nutr ;— Nielsen JV, Gando C, Joensson E, et al. Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: A clinical audit.

Diabetol Metab Syndr ; Ranjan A, Schmidt S, Damm-Frydenberg C, et al. Low-carbohydrate diet impairs the effect of glucagon in the treatment of insulin-induced mild hypoglycemia: A randomized crossover study.

Diabetes Care ;—5. Ranjan A, Schmidt S, Madsbad S, et al. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes. Jenkins DJ, Wolever TM, Taylor RH, et al. Glycemic index of foods: A physiological basis for carbohydrate exchange.

Am J Clin Nutr ;—6. Atkinson FS, Foster-Powell K, Brand-Miller JC. International tables of glycemic index and glycemic load values: Diabetes Care ;—3. Jenkins DJ, Kendall CW, McKeown-Eyssen G, et al.

Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: A randomized trial. Brand-Miller J, Hayne S, Petocz P, et al.

Low-glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Opperman AM, Venter CS, Oosthuizen W, et al. Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr ;— Thomas DE, Elliott EJ.

The use of low-glycaemic index diets in diabetes control. Wolever TM, Gibbs AL, Mehling C, et al. The Canadian Trial of Carbohydrates in Diabetes CCD , a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: No effect on glycated hemoglobin but reduction in C-reactive protein.

Am J Clin Nutr ;— Goff LM, Cowland DE, Hooper L, et al. Low glycaemic index diets and blood lipids: A systematic review and meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis ;— Ajala O, English P, Pinkney J.

Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Wang Q, Xia W, Zhao Z, et al. Effects comparison between low glycemic index diets and high glycemic index diets on HbA1c and fructosamine for patients with diabetes: A systematic review and meta-analysis.

Prim Care Diabetes ;—9. Mirrahimi A, de Souza RJ, Chiavaroli L, et al. Associations of glycemic index and load with coronary heart disease events: A systematic review and metaanalysis of prospective cohorts.

J Am Heart Assoc ;1:e Policy for labelling and advertising of dietary fibre-containing food products. Ottawa: Bureau of Nutritional Sciences Food Directorate, Health Products and Food Branch: Health Canada, Anderson JW, Randles KM, Kendall CW, et al.

Carbohydrate and fiber recommendations for individuals with diabetes: A quantitative assessment and metaanalysis of the evidence. J Am Coll Nutr ;— Grundy MM, Edwards CH, Mackie AR, et al.

Re-evaluation of the mechanisms of dietary fibre and implications for macronutrient bioaccessibility, digestion and postprandial metabolism.

Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan glucomannan improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Tiwari U, Cummins E. Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels.

Nutrition ;— Post RE, Mainous AG 3rd, King DE, et al. Dietary fiber for the treatment of type 2 diabetes mellitus: A meta-analysis.

J Am Board Fam Med ;— Brown L, Rosner B, Willett WW, et al. Cholesterol-lowering effects of dietary fiber: A meta-analysis. Ho HV, Sievenpiper JL, Zurbau A, et al.

A systematic review and metaanalysis of randomized controlled trials of the effect of barley beta-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reductioni-iv. Eur J Clin Nutr ;— The effect of oat beta-glucan on LDLcholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: A systematic review and meta-analysis of randomised-controlled trials.

Oat products and blood cholesterol lowering. Summary of assessment of a health claim about oat products and blood cholesterol lowering. Vuksan V, Jenkins AL, Jenkins DJ, et al.

Using cereal to increase dietary fiber intake to the recommended level and the effect of fiber on bowel function in healthy persons consuming North American diets. AmJ Clin Nutr ;— Jenkins DJ, Kendall CW, Augustin LS, et al.

Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care ;—8. Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: A randomized controlled trial.

Schoenaker DA, Toeller M, Chaturvedi N, et al. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: The EURODIAB Prospective Complications Study.

Threapleton DE, Greenwood DC, Evans CEL, et al. Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ ;f Chandalia M, Garg A, Lutjohann D, et al.

Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl JMed ;—8. Te Morenga LA, Howatson AJ, Jones RM, et al. Dietary sugars and cardiometabolic risk: Systematic review and meta-analyses of randomized controlled trials of the effects on blood pressure and lipids.

Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies.

BMJ ;e Choo VL, Cozma AI, Viguiliouk E, et al. The effect of fructose-containing sugars on glycemic control: A systematic review and meta-analysis of controlled trials. FASEB J ; Sievenpiper JL, de Souza RJ, Mirrahimi A, et al. Effect of fructose on body weight in controlled feeding trials: A systematic review and meta-analysis.

Ann Intern Med ;— Sievenpiper JL, Chiavaroli L, de Souza RJ, et al. Ha V, Sievenpiper JL, De Souza RJ, et al. Effect of fructose on blood pressure: A systematic review and meta-analysis of controlled feeding trials. Hypertension ;— Sievenpiper JL, Carleton AJ, Chatha S, et al.

Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: Systematic review and meta-analysis of experimental trials in humans.

Chiavaroli L, de Souza RJ, Ha V, et al. Effect of fructose on established lipid targets: A systematic review and meta-analysis of controlled feeding trials.

J Am Heart Assoc ;4:e Wang X, Ouyang Y, Liu J, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response meta-analysis of prospective cohort studies.

BMJ ;g Chiu S, Sievenpiper JL, de Souza RJ, et al. Effect of fructose on markers of nonalcoholic fatty liver disease NAFLD : a systematic review and meta-analysis of controlled feeding trials.

Wang DD, Sievenpiper JL, de Souza RJ, et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr ;— Cozma AI, Sievenpiper JL, de Souza RJ, et al. Effect of fructose on glycemic control in diabetes: A systematic review and meta-analysis of controlled feeding trials.

Livesey G, Taylor R. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: Meta-analyses and meta-regression models of intervention studies.

Lowndes J, Kawiecki D, Pardo S, et al. The effects of four hypocaloric diets containing different levels of sucrose or high fructose corn syrup on weight loss and related parameters. Nutr J ; Bravo S, Lowndes J, Sinnett S, et al.

Consumption of sucrose and highfructose corn syrup does not increase liver fat or ectopic fat deposition in muscles. Appl Physiol Nutr Metab ;—8. Lowndes J, Sinnett S, Pardo S, et al. Nutrients ;— Lowndes J, Sinnett S, Yu Z, et al. The effects of fructose-containing sugars on weight, body composition and cardiometabolic risk factors when consumed at up to the 90th percentile population consumption level for fructose.

Xi B, Huang Y, Reilly KH, et al. Sugar-sweetened beverages and risk of hypertension and CVD: A dose-response meta-analysis. Jayalath VH, de Souza RJ, Ha V, et al. Sugar-sweetened beverage consumption and incident hypertension: A systematic review and meta-analysis of prospective cohorts.

Jayalath VH, Sievenpiper JL, de Souza RJ, et al. Total fructose intake and risk of hypertension: A systematic review and meta-analysis of prospective cohorts. Tasevska N, Park Y, Jiao L, et al. Sugars and risk of mortality in the NIH-AARP Diet and Health Study. Liu S, Willett WC, Stampfer MJ, et al.

A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Beulens JW, de Bruijne LM, Stolk RP, et al. High dietary glycemic load and glycemic index increase risk of cardiovascular disease among middle-agedwomen: A population-based follow-up study.

J Am Coll Cardiol ;— Sieri S, Krogh V, Berrino F, et al. Dietary glycemic load and index and risk of coronary heart disease in a large italian cohort: The EPICOR study. Arch Intern Med ;—7. Burger KN, Beulens JW, Boer JM, et al. Dietary glycemic load and glycemic index and risk of coronary heart disease and stroke in Dutch men and women: The EPIC-MORGEN study.

PLoS ONE ;6:e Burger KN, Beulens JW, van der Schouw YT, et al. Dietary fiber, carbohydrate quality and quantity, and mortality risk of individuals with diabetes mellitus. PLoS ONE ;7:e Tsilas CS, de Souza RJ, Mejia SB, et al. Relation of total sugars, fructose and sucrose with incident type 2 diabetes: a systematic review and metaanalysis of prospective cohort studies.

CMAJ ; 20 :E— Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. Tang G,Wang D, Long J, et al. Meta-analysis of the association between whole grain intake and coronary heart disease risk. Am J Cardiol ;—9. Qin LQ, Xu JY, Han SF, et al.

Dairy consumption and risk of cardiovascular disease: An updated meta-analysis of prospective cohort studies. Smith JD, Hou T, Ludwig DS, et al. Changes in intake of protein foods, carbohydrate amount and quality, and long-term weight change: Results from 3 prospective cohorts.

Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults adult treatment panel III.

Yu-Poth S, Zhao G, Etherton T, et al. de Souza RJ, Mente A, Maroleanu A, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: Systematic review and meta-analysis of observational studies.

BMJ ;h Hooper L, Martin N, Abdelhamid A, et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev ; 6 :CD Ramsden CE, Zamora D, Leelarthaepin B, et al.

Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: Evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis.

Li Y, Hruby A, Bernstein AM, et al. Saturated fats compared with unsaturated fats and sources of carbohydrates in relation to risk of coronary heart disease: A prospective cohort study. Jakobsen MU, Dethlefsen C, Joensen AM, et al.

Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: Importance of the glycemic index. Am J Clin Nutr ;—8. de Oliveira Otto MC, Mozaffarian D, Kromhout D, et al.

Dietary intake of saturated fat by food source and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis. McEwen B, Morel-Kopp MC, Tofler G, et al. Effect of omega-3 fish oil on cardiovascular risk in diabetes.

Diabetes Educ ;— Kromhout D, Giltay EJ, Geleijnse JM, et al. n—3 fatty acids and cardiovascular events after myocardial infarction. The ORIGIN Trial Investigators, Bosch J, Gerstein HC, et al. n—3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. Chowdhury R,Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: A systematic review and meta-analysis.

Erratum in: Ann Intern Med ; Hu FB, Cho E, Rexrode KM, et al. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation ;—7. Sala-Vila A, Díaz-López A, Valls-Pedret C, et al. Dietary marine ω-3 fatty acids and incident sight-threatening retinopathy in middle-aged and older individuals with type 2 diabetes: Prospective investigation from the PREDIMED trial.

JAMA Ophthalmol ;—9. Lee CC, Sharp SJ, Wexler DJ, et al. Dietary intake of eicosapentaenoic and docosahexaenoic acid and diabetic nephropathy: Cohort analysis of the diabetes control and complications trial.

Diabetes Care ;—6. Hamdy O, Horton ES. Protein content in diabetes nutrition plan. Curr Diab Rep ;— Viguiliouk E, Stewart SE, Jayalath VH, et al. Effect of replacing animal protein with plant protein on glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled trials.

Hansen HP, Tauber-Lassen E, Jensen BR, et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int ;—8. Pan Y, Guo LL, Jin HM. Low-protein diet for diabetic nephropathy: A metaanalysis of randomized controlled trials.

Brodsky IG, Robbins DC, Hiser E, et al. Effects of low-protein diets on protein metabolism in insulin-dependent diabetes mellitus patients with early nephropathy.

J Clin Endocrinol Metab ;—7. Qian F, Korat AA, Malik V, et al. Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.

Jenkins DJ, Kendall CW, Vuksan V, et al. Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: A randomized controlled trial. Kodama S, Saito K, Tanaka S, et al. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: A metaanalysis.

Brinkworth GD, Noakes M, Parker B, et al. Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventionalweight-loss diet, in obese adults with type 2 diabetes: One-year follow-up of a randomised trial.

Larsen RN, Mann NJ, Maclean E, et al. The effect of high-protein, lowcarbohydrate diets in the treatment of type 2 diabetes: A 12 month randomised controlled trial. Haimoto H, Iwata M,Wakai K, et al.

Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: A 2-year follow-up study. Diabetes Res Clin Pract ;—6. Davis NJ, Tomuta N, Schechter C, et al.

Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet onweight and glycemic control in type 2 diabetes. Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetesrelated microvascular complications: The China Da Qing Diabetes Prevention Outcome Study.

Diabetologia ;—7. Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: A year follow-up study.

Lancet Diabetes Endocrinol ;— Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Prior AM, Thapa M, Hua DH. Aldose reductase inhibitors and nanodelivery of diabetic therapeutics.

Mini Rev Med Chem ;— Mann JI, De Leeuw I, Hermansen K, et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Coppell KJ, Kataoka M, Williams SM, et al. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—Lifestyle Over and Above Drugs in Diabetes LOADD study: Randomised controlled trial.

BMJ ;c WillettWC, Sacks F, Trichopoulou A, et al. Mediterranean diet pyramid: A cultural model for healthy eating. Am J Clin Nutr ;s—6s.

Trichopoulou A, Costacou T, Bamia C, et al. Adherence to a Mediterranean diet and survival in a Greek population.

Carter P, Achana F, Troughton J, et al. A Mediterranean diet improves HbA1c but not fasting blood glucose compared to alternative dietary strategies: A network meta-analysis. J Hum Nutr Diet ;— Esposito K, Maiorino MI, Ceriello A, et al. Prevention and control of type 2 diabetes by Mediterranean diet: A systematic review.

Sleiman D, Al-Badri MR, Azar ST. Effect of Mediterranean diet in diabetes control and cardiovascular risk modification: A systematic review. Front Public Health ; Esposito K, Maiorino MI, Petrizzo M, et al.

The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: Follow-up of a randomized trial. Elhayany A, Lustman A, Abel R, et al.

A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: A 1-year prospective randomized intervention study.

Diabetes Obes Metab ;—9. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. Díaz-López A, Babio N, Martínez-González MA, et al. Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: A post hoc analysis of a randomized trial.

A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: A randomized, controlled, wk clinical trial. Am J Clin Nutr ;s—96s.

Yokoyama Y, Barnard ND, Levin SM, et al. Vegetarian diets and glycemic control in diabetes: A systematic review and meta-analysis. Cardiovasc Diagn Ther ;— Viguiliouk E, Kahleová H, Rahelic´ D. Vegetarian diets improve glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled trials.

Proceedings of the 34th international symposium on diabetes and nutrition. Prague: Czech Republic, Barnard ND, Levin SM, Yokoyama Y. A systematic review and meta-analysis of changes in body weight in clinical trials of vegetarian diets.

J Acad Nutr Diet ;— Wang F, Zheng J, Yang B, et al. Effects of vegetarian diets on blood lipids: A systematic review and meta-analysis of randomized controlled trials. Jenkins DJ, Wong JM, Kendall CW, et al.

Jenkins DJA, Wong JMW, Kendall CWC, et al. BMJ Open ; Dinu M, Abbate R, Gensini GF, et al. Vegetarian, vegan diets and multiple health outcomes: A systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr in press. Food and Nutrition Board, Institute of Medicine.

Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Thomas MC, Moran J, Forsblom C, et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Ekinci EI, Clarke S, Thomas MC, et al.

Dietary salt intake and mortality in patients with type 2 diabetes. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure.

Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension DASH diet. DASH-Sodium Collaborative Research Group. Siervo M, Lara J, Chowdhury S, et al. Effects of the dietary approach to stop hypertension DASH diet on cardiovascular risk factors: A systematic review and meta-analysis.

Azadbakht L, Fard NR, Karimi M, et al. Effects of the Dietary Approaches to Stop Hypertension DASH eating plan on cardiovascular risks among type 2 diabetic patients: A randomized crossover clinical trial.

Azadbakht L, Surkan PJ, Esmaillzadeh A, et al. The dietary approaches to stop hypertension eating plan affects C-reactiabnormalitiesve protein, coagulation, and hepatic function tests among type 2 diabetic patients.

J Nutr ;—8. Schwingshackl L, Hoffmann G. Diet quality as assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches to Stop Hypertension score, and health outcomes: A systematic review and meta-analysis of cohort studies.

J Acad Nutr Diet ;—, e5. Jenkins DJ, Kendall CW, Marchie A, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. Jenkins DJ, Jones PJ, Lamarche B, et al.

Effect of a dietary portfolio of cholesterollowering foods given at 2 levels of intensity of dietary advice on serum lipids in hyperlipidemia: A randomized controlled trial.

JAMA ;—9. Lovejoy JC, Most MM, Lefevre M, et al. Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes.

Jenkins DJ, Mirrahimi A, Srichaikul K, et al. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr ;s—11s. Tokede OA, Onabanjo TA, Yansane A, et al. Soya products and serum lipids: A meta-analysis of randomised controlled trials. Ras RT, Geleijnse JM, Trautwein EA.

LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: Ameta-analysis of randomised controlled studies. Nordic Council. Nordic nutrition recommendations integrating nutrition and physical acitivity.

Arhus, Denmark: Nordic Council of Ministers, Adamsson V, Reumark A, Fredriksson IB, et al. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: A randomized controlled trial NORDIET.

J Intern Med ;—9. Uusitupa M, Hermansen K, Savolainen MJ, et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome—arandomized study SYSDIET.

J InternMed ;— Poulsen SK, Due A, Jordy AB, et al. Health effect of the NewNordic Diet in adults with increased waist circumference: A 6-mo randomized controlled trial.

Nordmann AJ, Nordmann A, Briel M, et al. Effects of low-carbohydrate vs lowfat diets onweight loss and cardiovascular risk factors: Ameta-analysis of randomized controlled trials.

Stern L, Iqbal N, Seshadri P, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: One-year follow-up of a randomized trial.

Shai I, Schwarzfuchs D, Henkin Y, et al. Weight Loss with a low-carbohydrate, Mediterranean, or low-fat diet. Dansinger ML, Gleason JA, Griffith JL, et al. Comparison of the Atkins, Ornish, WeightWatchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial.

Sievenpiper JL, Kendall CW, Esfahani A, et al. Effect of non-oil-seed pulses on glycaemic control: A systematic reviewand meta-analysis of randomised controlled experimental trials in people with and without diabetes.

Ha V, Sievenpiper JL, de Souza RJ, et al. Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: A systematic reviewandmeta-analysis of randomized controlled trials.

CMAJ ;E— Jayalath VH, de Souza RJ, Sievenpiper JL, et al. Effect of dietary pulses on blood pressure: A systematic review and meta-analysis of controlled feeding trials. Am J Hypertens ;— Kim SJ, de Souza RJ, Choo VL, et al. Effects of dietary pulse consumption on body weight: A systematic review and meta-analysis of randomized controlled trials.

Hosseinpour-Niazi S, Mirmiran P, Hedayati M, et al. Substitution of red meat with legumes in the therapeutic lifestyle change diet based on dietary advice improves cardiometabolic risk factors in overweight type 2 diabetes patients: A cross-over randomized clinical trial.

Eur J Clin Nutr ;—7. Afshin A, Micha R, Khatibzadeh S, et al. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: A systematic review and meta-analysis. Health Canada. Ottawa: Health Products and Food Branch, Office of Nutrition and Promotion, Moazen S, Amani R, Homayouni Rad A, et al.

Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: A randomized double-blind controlled trial.

Ann Nutr Metab ;— Hegde SV, Adhikari P, Nandini M, et al. Effect of daily supplementation of fruits on oxidative stress indices and glycaemic status in type 2 diabetes mellitus.

Complement Ther Clin Pract ;— Imai S, Matsuda M, Hasegawa G, et al. Asia Pac J Clin Nutr ;—8. Shin JY, Kim JY, Kang HT, et al. Effect of fruits and vegetables on metabolic syndrome: A systematic reviewand meta-analysis of randomized controlled trials. Int J Food Sci Nutr ;— Petersen KS, Clifton PM, Blanch N, et al.

Effect of improving dietary quality on carotid intima media thickness in subjects with type 1 and type 2 diabetes: A mo randomized controlled trial.

Am J Clin Nutr ;—9. Viguiliouk E, Kendall CW, Blanco Mejia S, et al. Effect of tree nuts on glycemic control in diabetes: A systematic reviewand meta-analysis of randomized controlled dietary trials.

Endocrinol Metab Clin North Am ;9:e Blanco Mejia S, Kendall CW, Viguiliouk E, et al. Effect of tree nuts onmetabolic syndrome criteria: A systematic reviewand meta-analysis of randomised controlled trials.

BMJ Open ;4:e Sabate J, Oda K, Ros E. Nut consumption and blood lipid levels: A pooled analysis of 25 intervention trials. Flores-Mateo G, Rojas-Rueda D, Basora J, et al.

Nut intake and adiposity:Metaanalysis of clinical trials. Whole grains—get the facts. Ottawa: Health Canada, Hollænder PL, Ross AB, Kristensen M. Whole-grain and blood lipid changes in apparently healthy adults: A systematic reviewand meta-analysis of randomized controlled studies.

Bao L, Cai X, Xu M, et al. Effect of oat intake on glycaemic control and insulin sensitivity: A meta-analysis of randomised controlled trials. Chen M, Pan A, Malik VS, et al. Effects of dairy intake on body weight and fat: Ameta-analysis of randomized controlled trials.

However, with insulin deficiency as in those with Type 1 diabetes, and with those that have had type 2 diabetes for a long time , the pancreas still secretes glucagon when amino acids appear in the blood. When there is no insulin to balance the glucagon, blood sugar levels rise as the liver releases stored sugar.

Some individuals have found that if their diabetes is well controlled, large amounts of protein have the potential to contribute to glucose production, minimally increase blood glucose levels, and require additional small amounts of insulin. Fat has little, if any, effect on blood glucose levels, although a high fat intake does appear to contribute to insulin resistance which would require more insulin.

Many individuals on insulin pumps have seen this happen, where a high fat meal causes delayed hyperglycemia high blood sugar 3—5 hours after eating and they need additional insulin delivered over several hours.

If you thinking about adjusting your insulin requirements on your own, talk to your Certified Diabetes Educator first. The goal is to have a balanced consumption of foods that come from all 3 macronutrient categories. The food that you eat is just one factor which influences your blood sugar level.

Check out this visual from DiaTribe that explains the 42 different factors that influence blood sugar! InControl Nutrition. About us. Work with us Consultations. Contact Us. Diabetes Blog. How do protein, fat and carbs affect my blood sugar levels?

Lets take a deeper look into all 3 of the macronutrients: Carbohydrates There are 2 types of carbohydrates — simple and complex. Protein Protein has a minimal effect on blood glucose levels if there is adequate insulin. Fat Fat has little, if any, effect on blood glucose levels, although a high fat intake does appear to contribute to insulin resistance which would require more insulin.

Maja Mirkovic March 8, InControl Nutrition LLC Comment.

For people with diabetes, diabetci carbohydrates often takes center stage when managing their dibetic. Diets containing a lot of saturated fat are Teeth replacement options with a higher risk of heart disease and stroke, which are dor comorbidities for Macronutrient sources for diabetic individuals. Macronutrjent the siurces kinds of fats in foods Marconutrient their effects on blood sugars is an important part of diabetes management. In fact, eating a balanced meal or snack that includes some fat can lead to more stable glucose levels. Fat, along with protein and fiber, slows digestion which also slows down the absorption of carbohydrates and smooths out the glucose spikes they can cause. Current dietary guidelines in the Dietary Guidelines for Americans have moved away from recommending strict limits and amounts on the macronutrients and food groups people should eat. New guidelines embrace a more inclusive approach that recognizes and supports the need for personalized and culturally inclusive recommendations.

Author: Ditilar

4 thoughts on “Macronutrient sources for diabetic individuals

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com